Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 4 | 2024 | 507 | 1.160 |
Why?
|
| Exercise Test | 2 | 2016 | 256 | 0.820 |
Why?
|
| Fellowships and Scholarships | 2 | 2024 | 286 | 0.740 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 525 | 0.660 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 149 | 0.600 |
Why?
|
| Crowdsourcing | 1 | 2018 | 10 | 0.600 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2019 | 117 | 0.570 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 215 | 0.560 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 193 | 0.550 |
Why?
|
| Aortic Diseases | 1 | 2019 | 199 | 0.520 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 200 | 0.490 |
Why?
|
| Pediatrics | 2 | 2024 | 1161 | 0.490 |
Why?
|
| Consensus | 1 | 2018 | 655 | 0.470 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 25 | 0.470 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 527 | 0.440 |
Why?
|
| Coronary Angiography | 2 | 2016 | 450 | 0.440 |
Why?
|
| Thrombosis | 1 | 2019 | 524 | 0.430 |
Why?
|
| Heart Septal Defects | 3 | 2018 | 38 | 0.430 |
Why?
|
| Fontan Procedure | 1 | 2016 | 185 | 0.420 |
Why?
|
| Down Syndrome | 1 | 2016 | 203 | 0.410 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 257 | 0.400 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 193 | 0.400 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 349 | 0.400 |
Why?
|
| Arterial Pressure | 1 | 2012 | 112 | 0.380 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 442 | 0.370 |
Why?
|
| Education, Distance | 2 | 2024 | 64 | 0.370 |
Why?
|
| Chest Pain | 1 | 2012 | 131 | 0.370 |
Why?
|
| Heart Ventricles | 1 | 2016 | 784 | 0.360 |
Why?
|
| Heart Defects, Congenital | 5 | 2020 | 1838 | 0.350 |
Why?
|
| Electrocardiography | 1 | 2016 | 981 | 0.340 |
Why?
|
| Echocardiography | 4 | 2020 | 1075 | 0.320 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 440 | 0.310 |
Why?
|
| Heart Diseases | 1 | 2012 | 503 | 0.280 |
Why?
|
| Child | 12 | 2021 | 24740 | 0.260 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1028 | 0.250 |
Why?
|
| LIM Domain Proteins | 2 | 2014 | 62 | 0.210 |
Why?
|
| Humans | 22 | 2024 | 126285 | 0.190 |
Why?
|
| Heart Murmurs | 1 | 2021 | 15 | 0.190 |
Why?
|
| Heart Failure | 1 | 2015 | 2309 | 0.180 |
Why?
|
| Job Application | 1 | 2021 | 19 | 0.180 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 90 | 0.170 |
Why?
|
| Physical Examination | 1 | 2021 | 159 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2020 | 31 | 0.170 |
Why?
|
| Myxoma | 1 | 2020 | 30 | 0.170 |
Why?
|
| Clinical Competence | 3 | 2024 | 1008 | 0.170 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 80 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2018 | 1130 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 144 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 569 | 0.160 |
Why?
|
| Career Choice | 1 | 2021 | 153 | 0.160 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 771 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 103 | 0.160 |
Why?
|
| Tetralogy of Fallot | 1 | 2020 | 164 | 0.150 |
Why?
|
| Male | 9 | 2020 | 62009 | 0.150 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 178 | 0.150 |
Why?
|
| Infant | 5 | 2020 | 12667 | 0.140 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 134 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 203 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2020 | 16514 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 198 | 0.140 |
Why?
|
| Learning | 1 | 2020 | 364 | 0.140 |
Why?
|
| Aortic Valve | 1 | 2020 | 447 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2024 | 1189 | 0.130 |
Why?
|
| Risk Factors | 4 | 2018 | 10372 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1909 | 0.130 |
Why?
|
| Aorta | 1 | 2020 | 548 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 376 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 1378 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2016 | 188 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 526 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 872 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 203 | 0.110 |
Why?
|
| Muscle, Striated | 1 | 2014 | 10 | 0.110 |
Why?
|
| Enalapril | 1 | 2014 | 14 | 0.110 |
Why?
|
| Captopril | 1 | 2014 | 27 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 577 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2016 | 165 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2014 | 416 | 0.110 |
Why?
|
| Female | 10 | 2020 | 67310 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8302 | 0.110 |
Why?
|
| Adolescent | 4 | 2018 | 19531 | 0.110 |
Why?
|
| Myocarditis | 1 | 2015 | 132 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1072 | 0.100 |
Why?
|
| Texas | 2 | 2024 | 3586 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 219 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 2012 | 58 | 0.100 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2012 | 40 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2012 | 98 | 0.100 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2012 | 44 | 0.100 |
Why?
|
| Palliative Care | 1 | 2016 | 440 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2012 | 148 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2015 | 596 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3715 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 463 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3622 | 0.090 |
Why?
|
| Survival Rate | 1 | 2016 | 2068 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5199 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 506 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 745 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 487 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 171 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 832 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2012 | 397 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2012 | 550 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3034 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2015 | 864 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1277 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2018 | 3078 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2011 | 533 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 651 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2194 | 0.070 |
Why?
|
| Age Factors | 1 | 2012 | 2834 | 0.060 |
Why?
|
| Ireland | 1 | 2024 | 28 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12379 | 0.050 |
Why?
|
| Prognosis | 1 | 2012 | 4731 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 4637 | 0.050 |
Why?
|
| Facial Paralysis | 1 | 2020 | 34 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 27 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 95 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2020 | 87 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 3459 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 6334 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 9165 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 2735 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 198 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 355 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 943 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 513 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 835 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 876 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 735 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1436 | 0.030 |
Why?
|
| Ankyrin Repeat | 1 | 2014 | 5 | 0.030 |
Why?
|
| Actinin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2014 | 12 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 49 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 72 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 81 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 117 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1193 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1034 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 403 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 2012 | 11 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 14208 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 371 | 0.030 |
Why?
|
| Connectin | 1 | 2012 | 27 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2012 | 37 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 395 | 0.020 |
Why?
|
| Azepines | 1 | 2012 | 64 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 484 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 286 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1305 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1749 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6175 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 664 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1713 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 836 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3762 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1361 | 0.020 |
Why?
|
| Animals | 2 | 2014 | 34519 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 5956 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17864 | 0.010 |
Why?
|